Breast Cancer
Showing 49–68 of 68 results
Molecule : PalbociclibManufacturer : Natco Pharma
Molecule : PalbociclibManufacturer : Natco Pharma
Molecule : PertuzumabManufacturer : Roche
Molecule : Sacituzumab GovitecanManufacturer : Gilead
Molecule : TucatinibManufacturer : Seagen
Rated 5.00 out of 5
(1)
TUKYSA® (tucatinib) is an FDA-approved oral medication used to treat adults with certain types of HER2-positive metastatic breast cancer and HER2-positive, RAS wild-type metastatic colorectal cancer. It is a tyrosine kinase inhibitor (TKI) that targets HER2 protein signaling inside cancer cells, offering patients a well-tolerated and effective non-chemotherapy option — including those with brain metastases.
Molecule : LapatinibManufacturer : Novartis
Molecule : LarotrectinibManufacturer : Bayer Zydus Pharma Pvt Ltd
Molecule : ExemestaneManufacturer : Natco Pharma